TP53 rs121918239: Understanding This Rare Genetic Variant
The rs121918239 variant is a rare genetic change located in the TP53 gene. It is classified as a hypomorphic allele, meaning it may result in partial loss of protein function and is associated with an increased, though incomplete, predisposition to certain cancers later in life.
What each genotype means
Typical TP53 function
This genotype represents the most common genetic sequence at this position in the TP53 gene. It is considered the baseline or reference state, and individuals with this profile do not carry the specific hypomorphic variant associated with altered cancer risk at this site.
This is the most common genotype found in the vast majority of the global population.
Hypomorphic variant carrier
This genotype indicates you carry one copy of the hypomorphic TP53 variant. Research suggests this variant is associated with incomplete penetrance and a potential predisposition to late-onset cancer, meaning the risk is not as high or as early-onset as classic Li-Fraumeni syndrome mutations. Because TP53 variants can interact with other genetic modifiers, you should discuss these findings with a genetic counselor to understand your specific risk profile.
This genotype is rare, with higher observed frequencies in specific African and Asian populations.
Hypomorphic variant homozygous
This genotype indicates you carry two copies of the hypomorphic TP53 variant. This variant is characterized by intermediate transcriptional activity and is classified as hypomorphic rather than a complete loss-of-function mutation. While it is linked to a predisposition for cancer, the penetrance is incomplete, and you should consult with a medical professional or genetic counselor to discuss appropriate screening and clinical management.
This genotype is very rare across all global populations.
What is the rs121918239 Variant?
The rs121918239 variant is a specific single nucleotide polymorphism (SNP) found within the TP53 gene. In genetic terms, this variant represents a change in the DNA sequence that can alter the resulting protein's structure or function. Because TP53 is a critical gene for maintaining cellular health, researchers closely monitor variants that deviate from the standard sequence. This particular variant is categorized as a hypomorphic allele, which suggests that the p53 protein produced by this gene copy may retain some, but not all, of its normal biological activity. Unlike high-penetrance mutations that cause severe, early-onset syndromes, hypomorphic variants like rs121918239 are often associated with more subtle effects, leading to incomplete penetrance. This means that carrying the variant does not guarantee the development of a specific health condition, as other genetic and environmental factors play significant roles in individual outcomes.
The Role of the TP53 Gene
The TP53 gene provides instructions for making the p53 protein, which acts as a tumor suppressor. Often referred to as the 'guardian of the genome,' p53 plays a vital role in preventing cells from growing and dividing too rapidly or in an uncontrolled way. When DNA damage occurs, the p53 protein helps determine whether the cell should repair the damage or undergo programmed cell death, known as apoptosis. By regulating these processes, p53 prevents the accumulation of mutations that could lead to tumor formation. When a variant like rs121918239 affects this gene, the resulting protein may be less efficient at monitoring cellular integrity. While the body often has compensatory mechanisms, a reduction in p53 function can theoretically increase the risk of cancer over a person's lifetime. Understanding how this specific variant impacts p53 function is an active area of research in precision oncology.
Research and Clinical Significance
Current research classifies rs121918239 as a variant with moderate evidence regarding its clinical impact. Studies indicate that it is associated with a predisposition to cancer, but the risk is not as absolute or early-onset as the classic mutations linked to Li-Fraumeni syndrome. Because it is a hypomorphic variant, its effects are often described as having 'incomplete penetrance,' meaning that many individuals who carry the variant may never develop cancer. Scientists use functional assays and population data to study these variants, noting that they often exhibit intermediate activity compared to fully inactive or fully functional versions of the gene. Because the clinical picture is complex, this variant is often studied in the context of genetic modifiers—other genes or environmental factors that might influence whether the variant leads to disease. It is important to note that this information is for educational purposes and should not be used for self-diagnosis.
Population Frequency and Ancestry
The rs121918239 variant is considered rare in the general human population. Genomic databases, such as gnomAD, indicate that its frequency is very low, though it is observed more frequently in specific African and Asian populations. The presence of such variants at varying frequencies across different ancestral groups highlights the importance of diverse genomic research. When a variant is rare, it can be difficult for researchers to gather enough data to fully understand its penetrance and clinical risk. Consequently, the scientific community continues to refine its understanding of how this variant behaves in different genetic backgrounds. If you have received information about this variant from a genetic test, it is recommended that you discuss the findings with a qualified genetic counselor or your healthcare provider, who can help interpret the results in the context of your personal and family medical history.
Managing Genetic Information
Learning about a genetic variant like rs121918239 can raise many questions. It is essential to understand that genetic testing results are only one piece of a much larger health puzzle. Because this variant is associated with incomplete penetrance, it does not serve as a definitive predictor of future health. You cannot 'fix' or 'change' a genetic variant, but you can use this information to engage in informed discussions with your medical team. If you are concerned about cancer risk, your doctor may suggest personalized surveillance strategies based on your overall risk profile, rather than relying on a single SNP. Always avoid making medical decisions based solely on raw genetic data. Instead, prioritize consultations with professionals who can integrate your genetic information with clinical screenings, lifestyle factors, and family history to provide a comprehensive and accurate assessment of your health needs.
How common is this variant?
The rs121918239 variant is rare in the general population, with higher observed frequencies in specific African and Asian ancestral groups.
Frequently asked questions
What does it mean if I have a TP53 variant?
A TP53 variant means there is a change in the DNA sequence of the gene that produces the p53 protein. While some TP53 variants are linked to high cancer risk, others, like hypomorphic variants, have lower or incomplete penetrance and may not lead to disease.
Is rs121918239 the same as Li-Fraumeni syndrome?
No, rs121918239 is a specific variant that is distinct from the classic, high-penetrance mutations that typically cause Li-Fraumeni syndrome. It is generally associated with different clinical characteristics and lower penetrance.
Should I be worried if I carry this variant?
Genetic variants are only one factor in your overall health. Because this variant has incomplete penetrance, it does not mean you will definitely develop a health condition; you should discuss your results with a genetic counselor to understand your specific risk.
How can I find out if I have this variant?
This variant is typically identified through clinical-grade genetic testing ordered by a healthcare provider. If you have received results from a direct-to-consumer test, you should verify them with a clinical laboratory and discuss them with a doctor.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918239?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TP53
Functional 3' UTR polyadenylation signal polymorphism altering TP53 transcription termination, showing population-specific baseline carrier frequencies across global groups.
This variant (Pro72Arg) is subject to refined clinical interpretation guidelines established by the ClinGen TP53 Variant Curation Expert Panel to improve classification accuracy for Li-Fraumeni syndrome risk.
Pathogenic hotspot variant (p.Arg273His) in TP53 predisposing carriers to early-onset sarcomas, breast cancers, and leukemias.
Li-Fraumeni syndrome missense variant (p.Arg248Trp) causing loss of tumor suppressor function and multi-cancer predisposition.
Synonymous and regulatory variant in linkage with TP53 codon 72 that modulates blastocyst implantation competence and the risk of recurrent implantation failure.
This variant is a low-penetrance, hypomorphic allele of the TP53 gene that has been historically misclassified as a pathogenic cancer-associated variant.